The global Hypersomnia Drug market size was valued at US$ 456.7 million in 2024 and is projected to reach US$ 623.4 million by 2030, at a CAGR of 5.3% during the forecast period 2024-2030.
United States Hypersomnia Drug market size was valued at US$ 123.4 million in 2024 and is projected to reach US$ 167.8 million by 2030, at a CAGR of 5.2% during the forecast period 2024-2030.
Report Overview
Hypersomnia indicates frequent and excessive daytime sleepiness. It becomes necessary for patients suffering from hypersomnia to take short naps in-between the day time and sleep more than 10 hours at night. However, the naps do not provide any relief. Also, patients may feel disoriented and can have difficulty in moving. Due to hypersomnia patients may have restlessness, loss of appetite hallucinations and slow speech.
This report provides a deep insight into the global Hypersomnia Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hypersomnia Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hypersomnia Drug market in any manner.
Global Hypersomnia Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
- Teva
- Jazz Pharmaceuticals
- BIOPROJET
- AVADEL PHARMACEUTICALS
- GlaxoSmithKline
- Pfizer
- Theranexus
- Fisher & Paykel Healthcare
- Drive Medical
- Merck
Market Segmentation (by Type)
Market Segmentation (by Application)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Hypersomnia Drug Market
- Overview of the regional outlook of the Hypersomnia Drug Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the
major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Hypersomnia Drug
1.2 Key Market Segments
1.2.1 Hypersomnia Drug Segment by Type
1.2.2 Hypersomnia Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Hypersomnia Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Hypersomnia Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Hypersomnia Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Hypersomnia Drug Market Competitive Landscape
3.1 Global Hypersomnia Drug Sales by Manufacturers (2019-2024)
3.2 Global Hypersomnia Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Hypersomnia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hypersomnia Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Hypersomnia Drug Sales Sites, Area Served, Product Type
3.6 Hypersomnia Drug Market Competitive Situation and Trends
3.6.1 Hypersomnia Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hypersomnia Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Hypersomnia Drug Industry Chain Analysis
4.1 Hypersomnia Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Hypersomnia Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Hypersomnia Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hypersomnia Drug Sales Market Share by Type (2019-2024)
6.3 Global Hypersomnia Drug Market Size Market Share by Type (2019-2024)
6.4 Global Hypersomnia Drug Price by Type (2019-2024)
7 Hypersomnia Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hypersomnia Drug Market Sales by Application (2019-2024)
7.3 Global Hypersomnia Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Hypersomnia Drug Sales Growth Rate by Application (2019-2024)
8 Hypersomnia Drug Market Segmentation by Region
8.1 Global Hypersomnia Drug Sales by Region
8.1.1 Global Hypersomnia Drug Sales by Region
8.1.2 Global Hypersomnia Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Hypersomnia Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hypersomnia Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hypersomnia Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hypersomnia Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hypersomnia Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Teva
9.1.1 Teva Hypersomnia Drug Basic Information
9.1.2 Teva Hypersomnia Drug Product Overview
9.1.3 Teva Hypersomnia Drug Product Market Performance
9.1.4 Teva Business Overview
9.1.5 Teva Hypersomnia Drug SWOT Analysis
9.1.6 Teva Recent Developments
9.2 Jazz Pharmaceuticals
9.2.1 Jazz Pharmaceuticals Hypersomnia Drug Basic Information
9.2.2 Jazz Pharmaceuticals Hypersomnia Drug Product Overview
9.2.3 Jazz Pharmaceuticals Hypersomnia Drug Product Market Performance
9.2.4 Jazz Pharmaceuticals Business Overview
9.2.5 Jazz Pharmaceuticals Hypersomnia Drug SWOT Analysis
9.2.6 Jazz Pharmaceuticals Recent Developments
9.3 BIOPROJET
9.3.1 BIOPROJET Hypersomnia Drug Basic Information
9.3.2 BIOPROJET Hypersomnia Drug Product Overview
9.3.3 BIOPROJET Hypersomnia Drug Product Market Performance
9.3.4 BIOPROJET Hypersomnia Drug SWOT Analysis
9.3.5 BIOPROJET Business Overview
9.3.6 BIOPROJET Recent Developments
9.4 AVADEL PHARMACEUTICALS
9.4.1 AVADEL PHARMACEUTICALS Hypersomnia Drug Basic Information
9.4.2 AVADEL PHARMACEUTICALS Hypersomnia Drug Product Overview
9.4.3 AVADEL PHARMACEUTICALS Hypersomnia Drug Product Market Performance
9.4.4 AVADEL PHARMACEUTICALS Business Overview
9.4.5 AVADEL PHARMACEUTICALS Recent Developments
9.5 GlaxoSmithKline
9.5.1 GlaxoSmithKline Hypersomnia Drug Basic Information
9.5.2 GlaxoSmithKline Hypersomnia Drug Product Overview
9.5.3 GlaxoSmithKline Hypersomnia Drug Product Market Performance
9.5.4 GlaxoSmithKline Business Overview
9.5.5 GlaxoSmithKline Recent Developments
9.6 Pfizer
9.6.1 Pfizer Hypersomnia Drug Basic Information
9.6.2 Pfizer Hypersomnia Drug Product Overview
9.6.3 Pfizer Hypersomnia Drug Product Market Performance
9.6.4 Pfizer Business Overview
9.6.5 Pfizer Recent Developments
9.7 Theranexus
9.7.1 Theranexus Hypersomnia Drug Basic Information
9.7.2 Theranexus Hypersomnia Drug Product Overview
9.7.3 Theranexus Hypersomnia Drug Product Market Performance
9.7.4 Theranexus Business Overview
9.7.5 Theranexus Recent Developments
9.8 Fisher and Paykel Healthcare
9.8.1 Fisher and Paykel Healthcare Hypersomnia Drug Basic Information
9.8.2 Fisher and Paykel Healthcare Hypersomnia Drug Product Overview
9.8.3 Fisher and Paykel Healthcare Hypersomnia Drug Product Market Performance
9.8.4 Fisher and Paykel Healthcare Business Overview
9.8.5 Fisher and Paykel Healthcare Recent Developments
9.9 Drive Medical
9.9.1 Drive Medical Hypersomnia Drug Basic Information
9.9.2 Drive Medical Hypersomnia Drug Product Overview
9.9.3 Drive Medical Hypersomnia Drug Product Market Performance
9.9.4 Drive Medical Business Overview
9.9.5 Drive Medical Recent Developments
9.10 Merck
9.10.1 Merck Hypersomnia Drug Basic Information
9.10.2 Merck Hypersomnia Drug Product Overview
9.10.3 Merck Hypersomnia Drug Product Market Performance
9.10.4 Merck Business Overview
9.10.5 Merck Recent Developments
10 Hypersomnia Drug Market Forecast by Region
10.1 Global Hypersomnia Drug Market Size Forecast
10.2 Global Hypersomnia Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Hypersomnia Drug Market Size Forecast by Country
10.2.3 Asia Pacific Hypersomnia Drug Market Size Forecast by Region
10.2.4 South America Hypersomnia Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Hypersomnia Drug by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Hypersomnia Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Hypersomnia Drug by Type (2025-2030)
11.1.2 Global Hypersomnia Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Hypersomnia Drug by Type (2025-2030)
11.2 Global Hypersomnia Drug Market Forecast by Application (2025-2030)
11.2.1 Global Hypersomnia Drug Sales (K Units) Forecast by Application
11.2.2 Global Hypersomnia Drug Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hypersomnia Drug Market Size Comparison by Region (M USD)
Table 5. Global Hypersomnia Drug Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Hypersomnia Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Hypersomnia Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Hypersomnia Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypersomnia Drug as of 2022)
Table 10. Global Market Hypersomnia Drug Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Hypersomnia Drug Sales Sites and Area Served
Table 12. Manufacturers Hypersomnia Drug Product Type
Table 13. Global Hypersomnia Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Hypersomnia Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hypersomnia Drug Market Challenges
Table 22. Global Hypersomnia Drug Sales by Type (K Units)
Table 23. Global Hypersomnia Drug Market Size by Type (M USD)
Table 24. Global Hypersomnia Drug Sales (K Units) by Type (2019-2024)
Table 25. Global Hypersomnia Drug Sales Market Share by Type (2019-2024)
Table 26. Global Hypersomnia Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Hypersomnia Drug Market Size Share by Type (2019-2024)
Table 28. Global Hypersomnia Drug Price (USD/Unit) by Type (2019-2024)
Table 29. Global Hypersomnia Drug Sales (K Units) by Application
Table 30. Global Hypersomnia Drug Market Size by Application
Table 31. Global Hypersomnia Drug Sales by Application (2019-2024) & (K Units)
Table 32. Global Hypersomnia Drug Sales Market Share by Application (2019-2024)
Table 33. Global Hypersomnia Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Hypersomnia Drug Market Share by Application (2019-2024)
Table 35. Global Hypersomnia Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Hypersomnia Drug Sales by Region (2019-2024) & (K Units)
Table 37. Global Hypersomnia Drug Sales Market Share by Region (2019-2024)
Table 38. North America Hypersomnia Drug Sales by Country (2019-2024) & (K Units)
Table 39. Europe Hypersomnia Drug Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Hypersomnia Drug Sales by Region (2019-2024) & (K Units)
Table 41. South America Hypersomnia Drug Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Hypersomnia Drug Sales by Region (2019-2024) & (K Units)
Table 43. Teva Hypersomnia Drug Basic Information
Table 44. Teva Hypersomnia Drug Product Overview
Table 45. Teva Hypersomnia Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Teva Business Overview
Table 47. Teva Hypersomnia Drug SWOT Analysis
Table 48. Teva Recent Developments
Table 49. Jazz Pharmaceuticals Hypersomnia Drug Basic Information
Table 50. Jazz Pharmaceuticals Hypersomnia Drug Product Overview
Table 51. Jazz Pharmaceuticals Hypersomnia Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Jazz Pharmaceuticals Business Overview
Table 53. Jazz Pharmaceuticals Hypersomnia Drug SWOT Analysis
Table 54. Jazz Pharmaceuticals Recent Developments
Table 55. BIOPROJET Hypersomnia Drug Basic Information
Table 56. BIOPROJET Hypersomnia Drug Product Overview
Table 57. BIOPROJET Hypersomnia Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. BIOPROJET Hypersomnia Drug SWOT Analysis
Table 59. BIOPROJET Business Overview
Table 60. BIOPROJET Recent Developments
Table 61. AVADEL PHARMACEUTICALS Hypersomnia Drug Basic Information
Table 62. AVADEL PHARMACEUTICALS Hypersomnia Drug Product Overview
Table 63. AVADEL PHARMACEUTICALS Hypersomnia Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. AVADEL PHARMACEUTICALS Business Overview
Table 65. AVADEL PHARMACEUTICALS Recent Developments
Table 66. GlaxoSmithKline Hypersomnia Drug Basic Information
Table 67. GlaxoSmithKline Hypersomnia Drug Product Overview
Table 68. GlaxoSmithKline Hypersomnia Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. GlaxoSmithKline Business Overview
Table 70. GlaxoSmithKline Recent Developments
Table 71. Pfizer Hypersomnia Drug Basic Information
Table 72. Pfizer Hypersomnia Drug Product Overview
Table 73. Pfizer Hypersomnia Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Pfizer Business Overview
Table 75. Pfizer Recent Developments
Table 76. Theranexus Hypersomnia Drug Basic Information
Table 77. Theranexus Hypersomnia Drug Product Overview
Table 78. Theranexus Hypersomnia Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Theranexus Business Overview
Table 80. Theranexus Recent Developments
Table 81. Fisher and Paykel Healthcare Hypersomnia Drug Basic Information
Table 82. Fisher and Paykel Healthcare Hypersomnia Drug Product Overview
Table 83. Fisher and Paykel Healthcare Hypersomnia Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Fisher and Paykel Healthcare Business Overview
Table 85. Fisher and Paykel Healthcare Recent Developments
Table 86. Drive Medical Hypersomnia Drug Basic Information
Table 87. Drive Medical Hypersomnia Drug Product Overview
Table 88. Drive Medical Hypersomnia Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Drive Medical Business Overview
Table 90. Drive Medical Recent Developments
Table 91. Merck Hypersomnia Drug Basic Information
Table 92. Merck Hypersomnia Drug Product Overview
Table 93. Merck Hypersomnia Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Merck Business Overview
Table 95. Merck Recent Developments
Table 96. Global Hypersomnia Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Hypersomnia Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Hypersomnia Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Hypersomnia Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Hypersomnia Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Hypersomnia Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Hypersomnia Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Hypersomnia Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Hypersomnia Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Hypersomnia Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Hypersomnia Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Hypersomnia Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Hypersomnia Drug Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Hypersomnia Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Hypersomnia Drug Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Hypersomnia Drug Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Hypersomnia Drug Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Hypersomnia Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hypersomnia Drug Market Size (M USD), 2019-2030
Figure 5. Global Hypersomnia Drug Market Size (M USD) (2019-2030)
Figure 6. Global Hypersomnia Drug Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hypersomnia Drug Market Size by Country (M USD)
Figure 11. Hypersomnia Drug Sales Share by Manufacturers in 2023
Figure 12. Global Hypersomnia Drug Revenue Share by Manufacturers in 2023
Figure 13. Hypersomnia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Hypersomnia Drug Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Hypersomnia Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Hypersomnia Drug Market Share by Type
Figure 18. Sales Market Share of Hypersomnia Drug by Type (2019-2024)
Figure 19. Sales Market Share of Hypersomnia Drug by Type in 2023
Figure 20. Market Size Share of Hypersomnia Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Hypersomnia Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Hypersomnia Drug Market Share by Application
Figure 24. Global Hypersomnia Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Hypersomnia Drug Sales Market Share by Application in 2023
Figure 26. Global Hypersomnia Drug Market Share by Application (2019-2024)
Figure 27. Global Hypersomnia Drug Market Share by Application in 2023
Figure 28. Global Hypersomnia Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Hypersomnia Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Hypersomnia Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Hypersomnia Drug Sales Market Share by Country in 2023
Figure 32. U.S. Hypersomnia Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Hypersomnia Drug Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Hypersomnia Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Hypersomnia Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Hypersomnia Drug Sales Market Share by Country in 2023
Figure 37. Germany Hypersomnia Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Hypersomnia Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Hypersomnia Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Hypersomnia Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Hypersomnia Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Hypersomnia Drug Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Hypersomnia Drug Sales Market Share by Region in 2023
Figure 44. China Hypersomnia Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Hypersomnia Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Hypersomnia Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Hypersomnia Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Hypersomnia Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Hypersomnia Drug Sales and Growth Rate (K Units)
Figure 50. South America Hypersomnia Drug Sales Market Share by Country in 2023
Figure 51. Brazil Hypersomnia Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Hypersomnia Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Hypersomnia Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Hypersomnia Drug Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Hypersomnia Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Hypersomnia Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Hypersomnia Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Hypersomnia Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Hypersomnia Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Hypersomnia Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Hypersomnia Drug Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Hypersomnia Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Hypersomnia Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Hypersomnia Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Hypersomnia Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Hypersomnia Drug Market Share Forecast by Application (2025-2030)
